These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11904354)

  • 1. Aluminium and bone disease in chronic renal failure.
    Malluche HH
    Nephrol Dial Transplant; 2002; 17 Suppl 2():21-4. PubMed ID: 11904354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impact of aluminium overload in renal failure.
    Cannata-Andía JB; Fernández-Martín JL
    Nephrol Dial Transplant; 2002; 17 Suppl 2():9-12. PubMed ID: 11904351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Halse J; Flatmark A
    Nephrol Dial Transplant; 1990; 5(6):449-56. PubMed ID: 2122323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum-related bone disease.
    Malluche HH; Faugere MC
    Blood Purif; 1988; 6(1):1-15. PubMed ID: 3345241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload and bone disease in chronic dialysis patients.
    Van de Vyver FL; Visser WJ; D'Haese PC; De Broe ME
    Nephrol Dial Transplant; 1990; 5(9):781-7. PubMed ID: 2129351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.
    Ellis HA; McCarthy JH; Herrington J
    J Clin Pathol; 1979 Aug; 32(8):832-44. PubMed ID: 389958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminium toxicity in chronic renal insufficiency.
    Savory J; Bertholf RL; Wills MR
    Clin Endocrinol Metab; 1985 Aug; 14(3):681-702. PubMed ID: 3905084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG; Pødenphant J; Andersen JR
    Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?
    Jenkins DA; Gouldesbrough D; Smith GD; Cowie JF; Winney RJ
    Nephrol Dial Transplant; 1989; 4(1):51-6. PubMed ID: 2494599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationships in aluminium toxicity in humans.
    Coulson JM; Hughes BW
    Clin Toxicol (Phila); 2022 Apr; 60(4):415-428. PubMed ID: 35179097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of serum aluminium monitoring in dialysis patients: a multicentre study.
    D'Haese PC; Clement JP; Elseviers MM; Lamberts LV; Van de Vyver FL; Visser WJ; De Broe ME
    Nephrol Dial Transplant; 1990; 5(1):45-53. PubMed ID: 2109284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis.
    Smith AJ; Faugère MC; Abreo K; Fanti P; Julian B; Malluche HH
    Am J Nephrol; 1986; 6(4):275-83. PubMed ID: 3777036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ; Van de Vyver FL
    Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water content of aluminum, dialysis dementia, and osteomalacia.
    Wills MR; Savory J
    Environ Health Perspect; 1985 Nov; 63():141-7. PubMed ID: 3908086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iatrogenic aluminum osteopathy in a uremic infant].
    Koch H; Reich H; Franke D; Delling G
    Monatsschr Kinderheilkd; 1986 May; 134(5):279-81. PubMed ID: 3724766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal absorption of aluminium in renal failure.
    Drüeke TB
    Nephrol Dial Transplant; 2002; 17 Suppl 2():13-6. PubMed ID: 11904352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminium in bone from patients with renal failure.
    Parsons V; Davies C; Goode C; Ogg C; Siddiqui J
    Br Med J; 1971 Oct; 4(5782):273-5. PubMed ID: 5123910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.